Publication | Closed Access

Criteria To Assess in Vivo Performance of Sustained Release Products: Application to Diltiazem Formulations

Regenerative MedicineTissue EngineeringEngineeringMedicineTopical DrugPharmacotherapyWound HealingBiomedical EngineeringDiltiazem FormulationsSustained Release ProductsDrug Delivery SystemPharmacologyVivo PerformanceDelivery SystemRelease Mechanism